Jon is a Technology and Data expert in our Commercial Team, with extensive experience of helping businesses harness data, intellectual property, and emerging technology to drive growth.

Much of Jon's work focuses on the Life Sciences, Healthcare and Technology sectors, particularly where those sectors converge in the Digital Health space. Jon assists clients in this area by:

  • Negotiating technology contracts of all shapes and sizes, such as the software arrangements powering decentralised clinical trials, and R&D collaborations accelerating product development; and
  • Navigating a broad spectrum of data-related issues, such as assessing the privacy compliance of Digital Health solutions being brought to market and advising on the responsible licensing of biomedical data to train and validate AI models to enable rapid disease diagnosis and drug discoveries.

Jon is named in the GDR 100 2023, Global Data Review's annual report on the world's best data law firms, which ranks Osborne Clarke as a top 10 Global Elite law firm for data matters.

Helping you succeed in tomorrow's world

One of the most rewarding aspects of my role is making a positive impact by providing our market-leading expertise in health data law on a pro bono basis. A recent highlight was assisting a charity focused on patients with a rare genetic condition in creating an international digital patient registry. The registry has been transformative for the client and its patients, enabling global tracking of the disease's prevalence and progression, and accelerating research into developing treatments and cures.

Technology Transactions

Advised the healthcare team of a cloud computing multi-national on the supply of its core technology platform to one of the world's largest biomedical databases and research resources.

Negotiated £multi-million software licensing and services agreements related to the core brands of a leading 3D software solutions multinational.

Advised a pioneering gene therapy company focused on developing transformative dementia medicines on the licensing of decentralised clinical trials technology to accelerate discoveries.

Data

Supported a US health care multinational with privacy compliance in relation to the development, commercialisation and EMEA roll-out of several new innovative Digital Health products.

Advised a TechBio on its data licensing collaborations with multiple large-scale biomedical database and research resources, securing the client the rights to develop and train its AI models to analyse proteomics data to identify: patterns indicative of disease in its early stage; and those patients most likely to benefit from a particular treatment.

As part of the OC Ventures team provides early stage and growing Digital Health companies, and their VC backers, with the specialist data licensing support they need as they mature to become established market leaders. 

Contact Jon
  • +44 207 105 7798
  • English, French
    • Add to contacts

    Insights

    Showing 1 - 12 of 50